Abstract：This study aimed to report the clinical characteristics and COMP gene mutation of a family with pseudoachondroplasia (PSACH), a relatively rare spinal and epiphyseal dysplasia that is inherited as an autosomal dominant trait. Clinical information on a 5-year-2-month-old PSACH child and his parents was collected and analyzed. Diagnosis was confirmed by PCR amplification and direct sequencing of all the 19 exons and their flanking sequences of COMP gene, and the mutation was further ascertained by cloning analysis of exon 10. The child presented with short and stubby fingers, bow leg, short limb dwarfism and metaphysic broadening in long bone as well as lumbar lordosis. A mutation c.1048_1116del (p.Asn350_Asp372del) in exon 10, inherited from his father who did not demonstrate any phenotypic feature of PSACH, was detected in the child. PSACH was diagnosed definitively by means of COMP mutation analysis, on the basis of the child's clinical and imaging features. The non-penetrance phenomenon of COMP mutation was described for the first time in PSACH
LU Chun-Ting,GUO Li,ZAHNG Zhan-Hui et al. Clinical features and COMP gene mutation in a family with a pseudoachondroplasia child[J]. CJCP, 2013, 15(11): 937-941.
Briggs MD, Chapman KL. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations [J] . Hum Mutat, 2002, 19(5): 465-478.
[2]
Andrea SF, Sheila U. Nosology and classification of genetic skeletal disorders: 2006 revision [J] . Am J Med Genet A, 2007, 143A(1): 1-18.
[3]
Posey KL, Hecht JL. The role of cartilage oligomeric matrix protein(COMP) in skeletal disease [J] . Curr Drug Targets, 2008, 9(10): 869-877.
[4]
Mckeand I, Rotta J, Hecha JL. Natural history study of pseudoachondroplasia [J] . Am J Med Genet, 1996, 63(2): 406-410.
[5]
Rimoin DL, Rasmussen IM, Briggs MD, Biggs MD, Roughley PJ, Gruber HE, et al. A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix [J] . Hum Genet, 1994, 93(3): 236-242.
[6]
Wynne-Davies R, Hall CM, Young ID. Pseudoachondroplasia: clinical diagnosis at different ages and comparison of autosomal dominant and recessive types. A review of 32 patients(26 kindreds) [J] . J Med Genet, 1986, 23(5): 425-434.
[7]
Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene [J] . Nat Genet, 1995, 10(3):330-336.
[8]
Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FFB, Harrison WR, et al. Mutations in exon 17B of cartilage oligomeric matrix protein(COMP) cause pseudoachondroplasia [J] . Nat Genet, 1995, 10(3): 325-329.
[9]
Briggs MD, Rasmussen IM, Weber JL, Yuen J, Reinker K, Garber AP, et al. Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19 [J] . Genomics, 1993, 18(3): 656-660.
[10]
Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, et al. Characterization of human and mouse cartilage oligomeric matrix protein [J] . Genomics, 1994, 24(3): 435-439.
[11]
Oldberg A, Antonsson P, Lindblom K, Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins [J] . J Biol Chem, 1992, 267(31): 22346-22350.
[12]
Halasz K, Kassner A, Morgelin M, Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis [J] . J Biol Chem, 2007, 282(43): 31166-31173.
[13]
Xu K, Zhang Y, Ilalov K, Carlson CS, Feng JQ, Di Cesare PE, et al. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation [J] . J Biol Chem, 2007, 282(15): 11347-11355.
[14]
Gagarina V, Carlberg AL, Pereira-Mouries L, Hall DJ. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins [J] . J Biol Chem, 2008, 283(1): 648-659.
[15]
Duke J, Montufar-Solis D, Underwood ZL, Hecht JT. Apoptosis staining in cultured pseudoachondroplasia chondrocytes [J] . Apoptosis, 2003, 8(2): 191-197.
[16]
Chen TL, Stevens JW, Cole WQ, Hecht JT, Vertel BM. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH [J]. Matrix Biol, 2004, 23(7): 433-444.
[17]
Xie XM, Liao LH, Gao JZ, Luo XP. A novel COMP mutation in a Chinese patient with pseudoachondroplasia [J] . Gene, 2013, 521(1): 102-106.
[18]
Wang CH, Lin WD, Tsai A, Tsai FJ. Novel human pathological mutations. Gene symbol: COMP Disease: pseudoachondroplasia [J] . Hum Genet, 2009, 125(3): 350.
[19]
Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NST, et al. The Human Gene Mutation Database: 2008 update [J] . Genome Med, 2009, 1(1): 131-136.
[20]
Kennedy J, Jackson G, Ramsden S, Taylor J, Newman W, Wright MJ, et al. COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia [J] . Eur J Hum Genet, 2005, 13(5): 547-555.
[21]
Deere M, Sanford T, Ferguson HL, Daniels K, Hecht JT. Identification of twelve mutations in cartilage oligomeric matrix protein(COMP) in patients with pseudoachondroplasia [J] . Am J Med Genet, 1998, 80(5): 510-513.
[22]
Tufan AC, Satitoglu-Tufan NL, Jackson GC, Semerci CN, Solak S, Yagci B. Serum or plasma cartilage oligomeric matrix protein concentration as a diagnostic marker in pseudoachondroplasia: differential diagnosis of a family [J] . Eur J Hum Gent, 2007, 15(10): 1023-1028.
Jackson GC, Mittaz-Crettol L, Taylor JA, Mortier GR, Spranger J, Zabel B, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution [J] . Hum Mutat, 2012, 33(1): 144-157.
[29]
Mabuchi A, Manabe N, Haga N, Kitoh H, Lkeda T, Kawaji H, et al. Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia [J] . Hum Genet, 2003, 112(1): 84-90.
Ballhausen D, Bonafe L, Terhal P, Unger SL, Bellus G, Classen M, et al. Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W [J] . J Med Genet, 2003, 40(1): 65-71.
[34]
Hou J, Putkey JA, Hecht JT. Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding [J] . Cell Calcium, 2000, 27(6): 309-314.
[35]
Kvansakul M, Adams JC, Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats [J]. Embo J, 2004, 23(6): 1223-1233.
[36]
Kleerekoper Q, Hecht JT, Putkey JA. Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain [J] . J Biol Chem, 2002, 277(12): 10581-10589.
[37]
Carlson CB, Bernstein DA, Annis DS, Misenheimer TM, Hannah BL, Mosher DF, et al. Structure of the calcium-rich signature domain of human thrombospondin-2 [J] . Nat Struct Mol Biol, 2005, 12(10): 910-914.
Northrup H, Wheless JW, Bertin TK, Lewis RA. Variability of expression in tuberous sclerosis [J] . J Med Genet, 1993, 30(1): 41-43.
[40]
Moore AT, Fitzke F, Arden GB, Inglehearn CF, Keen TJ, Bhattacharya SS, et al. Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance:a clinical, electrophysiological, psychophysical, and molecular genetic study [J] . Br J Ophthalmol, 1993, 77(8): 473-479.
[41]
Barber JCK. Directly transmitted unbalanced chromosome abnormalities and euchromatic variants [J] . J Med Genet, 2005, 42(8): 609-629.
[42]
Sampson JR, Scahill SJ, Stephenson JB, Mann L, Connor JM. Genetic aspects of tuberous sclerosis in the west of Scotland [J] . J Med Genet, 1989, 26(1): 28-31.
[43]
Spranger M, Schapera J. Anomalous inheritance in a kindred with split hand, split foot malformation [J] . Eur J Pediatr, 1988, 147(2): 202-205.
[44]
Morrison AW, Bundey SE. The inheritance of ostosclerosis[J] . J Laryngol Otol, 1970, 84(9): 921-932.
[45]
Causse JR, Causse JB. Otospongiosis as a genetic disease: early detection, medical management, and prevention [J] . Am J Otol, 1984, 5(3): 211-223.
[46]
Kanazawa H, Tanaka H, Inoue M, Ymanaka Y, Namba N, Seino Y. Efficacy of growth hormone therapy for patients with skeletal dysplasis [J]. J Bone Miner Metab, 2003, 21(5): 307-310.
